Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 2
2021 2
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Results by year

Filters applied: . Clear all
Page 1
Prognostic Biomarkers in Pituitary Tumours: A Systematic Review.
Papadimitriou E, Chatzellis E, Dimitriadi A, Kaltsas GA, Theocharis S, Alexandraki KI. Papadimitriou E, et al. touchREV Endocrinol. 2023 Nov;19(2):42-53. doi: 10.17925/EE.2023.19.2.12. Epub 2023 Aug 9. touchREV Endocrinol. 2023. PMID: 38187082 Free PMC article. Review.
Assessment of Early Markers of Cardiovascular Risk in Polycystic Ovary Syndrome.
Alexandraki KI, Kandaraki EA, Poulia KA, Piperi C, Papadimitriou E, Papaioannou TG. Alexandraki KI, et al. Among authors: papadimitriou e. touchREV Endocrinol. 2021 Apr;17(1):37-53. doi: 10.17925/EE.2021.17.1.37. Epub 2021 Apr 28. touchREV Endocrinol. 2021. PMID: 35118445 Free PMC article. Review.
The Role of TPOAb in Thyroid-Associated Orbitopathy: A Systematic Review.
Kyriakos G, Patsouras A, Voutyritsa E, Gravvanis C, Papadimitriou E, Farmaki P, Quiles-Sánchez LV, Georgakopoulou VE, Damaskos C, Ríos-Vergara A, Marín-Martínez L, Diamantis E. Kyriakos G, et al. Among authors: papadimitriou e. Ocul Immunol Inflamm. 2022 Oct-Nov;30(7-8):1740-1746. doi: 10.1080/09273948.2021.1942498. Epub 2021 Jul 2. Ocul Immunol Inflamm. 2022. PMID: 34214014
Evaluation and refinement of the PRESTARt tool for identifying 12-14 year olds at high lifetime risk of developing type 2 diabetes compared to a clinicians assessment of risk: a cross-sectional study.
Gray LJ, Brady EM, Albaina O, Edwardson CL, Harrington D, Khunti K, Miksza J, Raposo JF, Smith E, Vazeou A, Vergara I, Weihrauch-Blüher S, Davies MJ; PRE-STARt Collaborative. Gray LJ, et al. BMC Endocr Disord. 2019 Jul 25;19(1):79. doi: 10.1186/s12902-019-0410-3. BMC Endocr Disord. 2019. PMID: 31345191 Free PMC article.